3
Announcements
Trials
Browse
Landscape
Status
Completed
55
Recruiting
32
Unknown
19
Active not recruiting
9
Terminated
8
Not yet recruiting
7
Withdrawn
5
Enrolling by invitation
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
5
Observational
2
Sponsor
Cancer Type
Thoracic
2
Other solid neoplasm
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Neoplasms
33
Breast Neoplasms
32
Lung Neoplasms
17
Colorectal Neoplasms
16
Prostatic Neoplasms
13
Carcinoma, Non-Small-Cell Lung
13
Hematologic Neoplasms
12
Stomach Neoplasms
11
Pancreatic Neoplasms
11
Carcinoma, Hepatocellular
11
Diabetes Mellitus
9
Melanoma
7
Disease
7
Colonic Neoplasms
7
Pulmonary Disease, Chronic Obstructive
6
Cardiovascular Diseases
6
Barrett Esophagus
6
Urinary Bladder Neoplasms
5
Rectal Neoplasms
5
Liver Neoplasms
5
Leukemia, Myeloid, Acute
5
Fatigue
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Pheochromocytoma
4
Myasthenia Gravis
4
Multiple Myeloma
4
Lymphoma, Non-Hodgkin
4
Lymphoma
4
Lymphatic Metastasis
4
Leiomyoma
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Observational
×
Small Cell Lung Carcinoma
×
Clear all
NCT06885424
2026-05-20
DESCENT-1
A2 Biotherapeutics Inc.
Enrolling by invitation
400 enrolled
NCT06730685
2026-02-12
PHILUCA
Zealand University Hospital
Enrolling by invitation
160 enrolled